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Abstract
Background:  Pyrethroid resistant mosquitoes are becoming increasingly common in parts of Africa. It is
important to identify alternative insecticides which, if necessary, could be used to replace or supplement the
pyrethroids for use on treated nets. Certain compounds of an earlier generation of insecticides, the
organophosphates may have potential as net treatments.
Methods: Comparative studies of chlorpyrifos-methyl (CM), an organophosphate with low mammalian toxicity,
and lambdacyhalothrin (L), a pyrethroid, were conducted in experimental huts in Côte d'Ivoire, West Africa.
Anopheles gambiae and  Culex quinquefasciatus mosquitoes from the area are resistant to pyrethroids and
organophosphates (kdr and insensitive acetylcholinesterase Ace.1R). Several treatments and application rates on
intact or holed nets were evaluated, including single treatments, mixtures, and differential wall/ceiling treatments.
Results and Conclusion: All of the treatments were effective in reducing blood feeding from sleepers under
the nets and in killing both species of mosquito, despite the presence of the kdr and Ace.1R genes at high frequency.
In most cases, the effects of the various treatments did not differ significantly. Five washes of the nets in soap
solution did not reduce the impact of the insecticides on A. gambiae mortality, but did lead to an increase in blood
feeding. The three combinations performed no differently from the single insecticide treatments, but the low dose
mixture performed encouragingly well indicating that such combinations might be used for controlling insecticide
resistant mosquitoes. Mortality of mosquitoes that carried both Ace.1R and Ace.1S genes did not differ significantly
from mosquitoes that carried only Ace.1S genes on any of the treated nets, indicating that the Ace.1R allele does
not confer effective resistance to chlorpyrifos-methyl under the realistic conditions of an experimental hut.
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Background
Insecticide-treated nets (ITN) are an important compo-
nent of the Roll Back Malaria campaign to reduce malaria
morbidity and mortality in Africa. Pyrethroids are the
only group of insecticides currently recommended for use
on nets [1]. In recent years, pyrethroid resistance has
become widespread among anopheline mosquitoes in
western Africa and has also arisen in eastern and southern
Africa [2-6]. Pyrethroid resistance has evolved concur-
rently in the filariasis vector and nuisance mosquito Culex
quinquefasciatus [7,8].
Initial alarm over the rapid spread of the kdr allele respon-
sible for pyrethoid resistance [9] has been tempered by
recent evidence which indicates that nets incorporating
permethrin continue to reduce malaria transmission and
morbidity in an area known to have a high frequency of
kdr [10]. Experimental hut studies in a similar area con-
firm that pyrethroid treated nets continue to kill pyre-
throid resistant mosquitoes [11-14]. However, in another
PCR genotyping hut study by Kolaczinski et al [15]
showed a significantly higher frequency of the kdr gene
among survivors of alphacypermethrin- or etofenprox-
treated nets than in mosquitoes which were killed by
these treatments. In Kenya, a different form of the kdr gene
was found in Anopheles gambiae by Ranson et al [5], in an
area where one of the most successful large-scale ITN trials
was subsequently carried out [16,17]. These findings may
allay initial fears but it would be complacent to assume
that pyrethroid-treated nets will remain effective indefi-
nitely. Selection of supplementary resistance mechanisms
could tip the balance towards control failure [3,18,19], as
happened with indoor residual spraying in South Africa
owing to selection of a metabolic form of resistance in
Anopheles funestus which required switching back to DDT
to restore malaria control [6]. The danger of pyrethroid
resistance is apparent in Tanzanian C. quinquefasciatus. It
effectively prevents mortality with pyrethroid treated nets
in experimental huts [20] and prevents Culex population
suppression when ITNs are used by whole communities,
in contrast to high mortality and population suppression
of susceptible A. gambiae populations under these condi-
tions [21].
Finding an alternative to the pyrethroids has, therefore,
become a priority [22]. Some members of the earlier gen-
eration of insecticides, the organophosphates (OPs) and
carbamates, although developed primarily for agricultural
use and for indoor residual spraying, may have potential
as net treatments. If there is a complete lack of cross-resist-
ance to pyrethroid resistant mosquitoes, use of such com-
pounds in combination with pyrethroids may provide an
opportunity for resistance management [23,24].
Experimental hut studies have shown that the perform-
ance of the carbamate carbosulfan on nets against pyre-
throid- resistant Anopheles and carbamate- resistant Culex
mosquitoes is equivalent or better than that of pyre-
throids against susceptible mosquitoes [14,15]. Because
of a perceived risk of human toxicity with a carbosulfan
breakdown product, carbofuran, some doubt has been
cast over the suitability of carbosulfan as a net treatment
[13,25]. Chlorpyrifos-methyl (Reldan®, Dow Agro-
Sciences), an OP used in agriculture to control stored
product pests, may be more suitable, being classified by
WHO as unlikely to present acute hazard in normal use,
whereas carbosulfan and the majority of pyrethroids rec-
ommended for treatment of mosquito nets are classified
by WHO as Class II, i.e. moderately hazardous [26].
Broad spectrum resistance to organophosphates and car-
bamates caused by insensitive acetylcholinesterase mech-
anisms have been identified in A. gambiae and  C.
quinquefasciatus from Côte d'Ivoire [4,27,28]. To assess the
potential of chlorpyrifos-methyl to control resistant
anophelines and culicines, the performance of nets
treated with chlorpyrifos-methyl, lambdacyhalothrin and
various combinations of the two was compared in experi-
mental huts near Bouaké, Côte d'Ivoire.
Materials and methods
Study area and experimental huts
The treated nets were evaluated in 11 experimental huts at
a field site of the Institut Pierre Richet in Yaokoffikro,
Bouaké, Côte d'Ivoire. The huts were situated near rice
and vegetable fields and arrayed in two rows with a 5
metre gap between huts. The style of the hut was typical of
the region. Each was made from concrete bricks, with a
corrugated iron roof, a ceiling of thick polyethylene sheet-
ing, and a concrete base surrounded by a water-filled
channel to prevent entry of ants [11]. Mosquito access was
via 4 window slits constructed from pieces of plywood,
fixed at an angle to create a funnel with a 1 cm wide gap.
Mosquitoes had to fly upward to enter through the gap
and downwards to exit; this precluded or, at worst, limited
exodus though the aperture enabling the majority of
entering mosquitoes to be accounted for. A verandah trap
made of polyethylene sheeting and screening mesh meas-
uring 2 m long, 1.5 m wide, and 1.5 m high, projected
from the back wall of each hut. Movement of mosquitoes
between hut and verandah was unimpeded. All huts were
thoroughly cleaned before the trial. Sheets were laid over
the floor each night to ease the collecting of knocked
down mosquitoes in the morning.
Bednets
The nets were made from white 100-denier polyester
(SiamDutch Mosquito Netting Co., Thailand). They
measured 1.9 m long, 1.8 m wide and 1.5 m high, and hadMalaria Journal 2005, 4:25 http://www.malariajournal.com/content/4/1/25
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a surface area of 14.5 m2. To simulate badly torn nets, 80
holes, each measuring 2 × 2 cm, were cut in the sides and
ends of all but two of the nets.
Insecticide treatment
The insecticides used were:
chlorpyrifos-methyl 38.8% CS ('Reldan GF934', Dow
AgroSciences), an experimental microencapsulated sus-
pension, designed for controlled residual activity and
short outdoor persistence).
lambdacyhalothrin 2.5% CS, ('Icon', Syngenta UK), a
commercial microencapsulated formulation.
Impregnation of nets was carried out using the formula of
Pleass et al [29] to calculate the amount of insecticide
needed. The nine treatments and target application rates
were:
lambdacyalothrin 18 mg/m2, holed, unwashed
lambdacyalothrin 18 mg/m2, holed, washed with soap 5
times
chlorpyrifos-methyl 100 mg/m2, holed, unwashed
chlorpyrifos-methyl 100 mg/m2, intact, washed with soap
5 times
chlorpyrifos-methyl 250 mg/m2, holed, unwashed
chlorpyrifos-methyl 250 mg/m2, holed, washed with soap
5 times
mixture of chlorpyrifos-methyl 100 mg/m2 and lambda-
cyalothrin 18 mg/m2, holed, unwashed
mixture of chlorpyrifos-methyl 25 mg/m2 and lambdacy-
alothrin 4.5 mg/m2, holed, unwashed
chlorpyrifos-methyl 100 mg/m2 on ceiling of net and
lambdacyalothrin 18 mg/m2 on walls, holed, unwashed.
Differential treatment of the ceiling and walls of a net has
been called "two-in-one" by Guillet et al [25] and a
"mosaic" by others [13]. However, the term mosaic is con-
ventionally used to describe a resistance management
strategy in which two or more chemicals are used for
spraying different sectors of countryside, the sectors being
large enough to contain their "own" mosquito popula-
tions in which different resistance gene frequencies would
evolve as a result of different selection pressures, with only
limited exchange of genes by immigration. Thus, in this
paper we have preferred to adopt the term "two-in-one",
suggested by Guillet et al [25].
untreated control, intact
untreated control, holed.
The application rate of 18 mg/m2 lambdacyalothrin was
the same as that used by Asidi et al [14] and was in the
application dose range proposed by WHO. The 100 mg/
m2  chlorpyrifos-methyl (CM) treatment was twice the
dosage needed to kill 100% of a laboratory OP resistant
strain (DUBAI 234) in a 3 min exposure bioassay test. To
assess the effect of repeated washing, a higher application
rate of CM was used initially (250 mg/m2). Washing was
done by hand using a palm-oil soap 'Maxi Mousse', and
was repeated five times with a one-day interval between
washes. The effect of holed versus intact nets was assessed
using untreated and 100 mg/m2 CM treatments. The mix-
ture of lambdacyhalothin and chlorpyrifos-methyl was
prepared with the two CS formulations mixed in water.
The intention with the low dose mixture (25 mg/m2 CM
and 4.5 mg/m2  lambdacyhalothin) was to examine
whether efficacy would be maintained after a period of
simulated insecticide decay or whether differential decay
might lead to selection of Ace.1R or kdr resistance geno-
types. The "two-in-one" net was prepared by cutting the
ceiling from the walls of the net, dipping the two sections
in chlorpyrifos-methyl and lambdacyhalothin respec-
tively, and then sewing the two sections together again.
Untreated intact and holed nets were used as controls.
Sleepers and mosquito collections
The treatments were randomly allocated to the eleven
experimental huts. Eleven adult men were paid to sleep in
the huts each night from 20.00 to 05.00 hours and to col-
lect mosquitoes in the mornings. The sleepers/collectors
were experienced in collecting mosquitoes, gave informed
consent and were given malaria chemoprophylaxis.
The trial ran for only 33 nights over 6 weeks (from 15
August 2002). The trial was planned to run for 44 nights
but had to be curtailed owing to political unrest. The
sleepers were rotated between huts to correct for possible
variation in individual attractiveness. The nets were not
rotated for fear of cross-contaminating huts with different
treatments. There was a risk in this experimental design of
not being able to separate possible confounding factors
due to variation in hut attractiveness independent from
that of treatment. However, baseline measurements indi-
cated that the huts were comparable in attractiveness
(Table 1). Sleepers were questioned each day during the
first two weeks to find out whether they experienced any
side effects from using nets.
Each dawn, the huts were searched and all mosquitoes
were collected from the floors, walls, and ceilings of
rooms, verandahs and nets. Mosquitoes were identifiedMalaria Journal 2005, 4:25 http://www.malariajournal.com/content/4/1/25
Page 4 of 9
(page number not for citation purposes)
and scored as blood-fed or unfed and dead or alive. Male
mosquitoes were not recorded. Live females were held in
netted plastic cups and supplied with 10% honey solution
for 24 h before recording any delayed mortality. All A.
gambiae and C. quinquefasciatus were kept for determina-
tion of kdr and Ace.1R genotypes.
DNA diagnostic test for the pyrethroid resistance kdr and 
insensitive acetylcholinesterase G119S mutations in single 
A. gambiae
Genomic DNA was extracted from single mosquitoes
according to Collins et al [30]. For determination of ace-
tylcholinesterase mutation, the DNA was PCR amplified
with the degenerate primers Moustdir1 5'CCG-
GGNGCSACYAT-GTGGAA3' and Moustrev1
5'ACGATMACGTTCTCYTCCGA3' for thirty cycles (94°C
for 30 seconds, 52°C for 30 seconds and 72°C for 1
minute), the PCR fragments were then digested with AluI
restriction enzyme according to the manufacturer's
instructions and fractionated on a 2% agarose gel accord-
ing to Weil et al [31]. Genotypes for pyrethroid resistance
kdr  "leu-phe" mutation were determined according to
Martinez-Torres et al [9].
Data analysis
The effect of each treatment was assessed relative to the
control in terms of deterrency (the number of mosquitoes
caught in each hut), excito-repellency (the proportion of
mosquitoes in the verandah traps), blood feeding inhibi-
tion and mortality rates. Proportional data were analysed
using logistic regression (STATA 6 software). Compari-
sons between treatments were made by successively drop-
ping treatments from the overall comparison and this
process allowed each treatment to be compared with every
other. Owing to non-normality of the data the numbers of
blood-fed and dead mosquitoes and overall totals col-
lected from each hut were compared using Wilcoxon rank
sum non-parametric tests. Genotype frequencies were
tested using χ 2 or Fisher's exact test.
Results
Mosquito abundance
To assess any difference in the attractiveness of the huts to
mosquitoes, preliminary collections were carried out over
100 hut-nights (10 huts × 10 nights) from late July 2002,
with the sleepers/collectors being rotated between huts on
successive nights (the 11th hut was being used for another
purpose at this time). A total of 1328 mosquitoes were
recorded of which 41.6% were A. gambiae, 19.4% Culex
spp., 31.6% Mansonia spp., 4.3% Aedes spp., 2% A. funes-
tus, 0.9% Anopheles pharaonsis, 0.5% Anopheles coustani,
0.2% Coquillettidia crystata and 0.1% Eretmapodites. There
were no significant differences between the huts in the
numbers of each species collected (F = 0.411 df = 9,9 P =
0.926) (Table 1).
Efficacy of treatment
From 363 hut-nights collections (33 days × 11 huts) a
total of 5,639 mosquitoes were recorded of which 10%
were A. gambiae and 45% Culex spp. (C. quinquefasciatus
predominated). The markedly lower A. gambiae frequency
than that mentioned in the previous paragraph was pre-
sumably due to a seasonal change. Of the remaining spe-
cies 23% were A. coustani, 35% Mansonia spp., 6% Aedes
spp., 0.4% A. funestus, and 1% A. pharaoensis with Coquil-
lettidia crystata and Eretmapodites being present in small
numbers. Only the malaria vector A. gambiae and the nui-
sance mosquito Culex  spp. were subjected to analysis.
Additional file 1 and Additional file 2 summarize the data
for A. gambiae and Culex spp., respectively. All types of
insecticide treatment appeared to deter entry of mosqui-
toes into huts, compared to that of untreated nets. Esti-
mated deterrency among A. gambiae ranged from 30%
with the low dosage mixture to 71% with lambdacy-
hothrin. However, the differences between treatments
never reached statistical significance among the relatively
small numbers of A. gambiae caught. Percentage deter-
rency among Culex spp. was less than the estimates for A.
gambiae, but was more often statistically significant
Table 1: Mean numbers of mosquitoes collected per night over 10 nights before installation of treated nets.
Hut number An. gambiae Other anophelines Culex spp. Aedes spp. Mansonia spp. Overall means
1 4.2 0.2 3.9 0.6 5.2 14.1
2 5.3 0.1 2.7 0.8 3.9 12.9
3 6.5 0.6 1.6 0.5 5.4 14.6
4 5.1 0.3 2.9 0.6 3.8 12.7
5 6.1 0.4 2.8 1.0 3.6 13.9
6 5.4 0.5 1.9 0.3 3.9 12.0
7 5.1 0.5 2.6 0.2 4.4 12.8
8 4.9 0.6 0.9 0.6 4.8 11.8
9 6.2 0.4 2.6 0.6 3.7 13.5
10 6.5 0.2 3.8 0.5 3.3 14.4Malaria Journal 2005, 4:25 http://www.malariajournal.com/content/4/1/25
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among the larger numbers caught. Estimated deterrency
of Culex spp. ranged from 36% with the washed chlorpy-
rifos-methyl treated net to 58% with the unwashed lamb-
dacyhalothrin net but the differences between unwashed
and washed nets were not significant.
Additional file 1 and Additional file 2 show data on mos-
quito feeding and mortality expressed either as mean
numbers per daily collection (cols. 9 and 12) or as per-
centages among those that entered the huts (cols. 6–8 and
10–11).
Untreated nets failed to give protection when holed: 39%
of  A. gambiae and 25% of Culex  spp. were blood-fed,
whereas with the intact net only 7% of A. gambiae and 2%
of  Culex  were blood-fed. Treatment with chlorpyrifos-
methyl or lambdacyhalothrin restored the capacity of
holed nets to inhibit blood feeding. After five washes of
the lambdacyhalothrin (18 mg/m2) or chlorpyrifos-
methyl (250 mg/m2) treated nets, the inhibition of blood
feeding shown by in A. gambiae was no longer statistically
significant. Among the Culex, on the other hand, blood
feeding remained significantly inhibited after washing,
both for lambdacyhalothrin and chlorpyrifos-methyl
treated nets. The proportion of A. gambiae and Culex killed
by lambdacyhalothrin or chlorpyrifos-methyl treatments
were similar before and after washing, indicating that the
treatments remained highly insecticidal even after 5
washes.
The treatments deterred A. gambiae from entering the
holed nets. The proportions collected from inside the nets
were 20.5% for the untreated nets, 10.0% for the chlorpy-
rifos-methyl treated nets and 9.0% for the lambdacyha-
lothrin treated nets (P < 0.01). No such effect was
observed against Culex, the proportion found inside the
nets showing little variation (8–9%) between the
untreated nets and nets treated with chlorpyrifos-methyl
or lambdacyhalothrin.
The mortality was consistently high among A. gambiae
and Culex regardless of the treatment used. An application
rate of 100 mg/m2 chlorpyrifos-methyl was sufficient to
kill 58% of A. gambiae and 68% of Culex (despite the fact
that many of the mosquitoes carried genes for Ace.1R),
and reduced the rate of blood feeding through the holed
nets by 62% among A. gambiae and 88% among Culex. An
increase in the application rate of chlorpyrifos-methyl
from 100 to 250 mg/m2 did not significantly increase the
mortality rates of A. gambiae and  Culex, but with the
higher dose there was complete inhibition of blood feed-
ing of A. gambiae. Most of the mortality was evident by
dawn and for most types of treatment less than 10% of
deaths occurred over the next 24 h. The two-in-one and
the high and low dose mixtures showed equivalent effi-
cacy. When compared to each insecticide applied as single
treatments the two-in-one and high dose mixture did not
appear to give either better protection against blood feed-
ing or higher mosquito mortality. The low dose mixture
was associated with mortality and blood-feeding rates
similar to that observed with the high dose mixture and
two-in-one treatments.
All treatments increased the proportion of mosquitoes in
the verandah traps. The magnitude of the excito-repellent
effect ranged from 16% to 40%. By this criterion, lamda-
cyhalothrin and chlorpyrifos-methyl were equally repel-
lent, and both Culex  and A. gambiae showed a similar
tendency to be repelled. With the greater numbers of mos-
quitoes collected, the "insecticide-induced exophily"
tended to be significant for Culex, but it was not signifi-
cant with the small A. gambiae samples.
Side-effects of treatments
In 154 interviews with sleepers recorded during the first
two weeks of the trial, 14 (9.1%) recorded sneezing and 5
five recorded severe headaches. Such symptoms occurred
during the first 10 days after treating the nets. The com-
plaints of headache were made, in every instance, after a
night spent under the unwashed net treated with 250 mg/
m2 chlorpyrifos-methyl.
Genotype frequencies
The frequency of the kdr gene in A. gambiae from the con-
trol huts was above 90%. With this high frequency the
sample sizes were considered too low to test satisfactorily
for any selective effect by treatments, and, therefore, the
collections from the treatment huts were not tested any
further for kdr. The high mortality obtained with the
lambdacyhalothrin treated nets indicates that this pyre-
throid, when present on nets, is still effective in control-
ling many kdr resistant mosquitoes.
The results of Ace.1  genotyping of 298 A. gambiae are
grouped into those found live or dead in the huts with
untreated control nets, or with nets treated with chlorpy-
rifos-methyl, lambdacyhalothrin or combinations of
these two insecticides (Table 2). The numbers identified
were two mosquitoes with Ace.1R only, 243 mosquitoes
with Ace.1R plus Ace.1S and 53 mosquitoes with Ace.1S
only. Assuming that the first type were homozygous for
Ace.1R, the third type were homozygous for Ace.1S and the
second type were heterozygous, the frequencies of the
Ace.1R and Ace.1S alleles would be 0.41 and 0.59 respec-
tively. According to conventional Hardy-Weinberg ratios
(P2, 2PQ, Q2) the frequency of Ace.1R/Ace.1R genotype was
expected to be 17.2% rather than the 0.7% actually
observed. This indicates a strong fitness disadvantage
associated with Ace.1R homozygotes or some alternative
genetic explanation.Malaria Journal 2005, 4:25 http://www.malariajournal.com/content/4/1/25
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Survival rates of Ace.1R/Ace.1S in huts with untreated nets
were lower than that of Ace.1S/Ace.1S suggesting a fitness
disadvantage. There was no apparent difference between
the survival rates of Ace.1R/Ace.1S and Ace.1S/Ace.1S in huts
with chlorpyrifos-methyl treated nets or other treatments.
Discussion
Where ITN-induced deterrency occurs, it will contribute to
reducing human/vector contact, and in households where
not everyone has access to a net, even non-users would be
expected to gain some indirect protection from mosquito
biting. However, deterrency will reduce the number of
mosquitoes killed and, hence, the potential for a commu-
nity-wide impact on the infective biting population. Thus,
the mean numbers found fed and dead in the huts are
more realistic indicators of the relative impact of the
treated nets than are the columns showing the propor-
tions fed and dead. However, the latter are also of interest
in giving an idea of the extent of the feeding inhibition
and insecticidal effects of the various treatments on mos-
quitoes exposed to them.
Nets treated with chlorpyrifos-methyl appeared to induce
a level of deterrency against A. gambiae similar to that of
the pyrethroid lambdacyhalothrin but the effects were not
statistically significant. Compared to other hut studies in
Côte d'Ivoire, the deterrency shown by chlorpyrifos-
methyl against C. quinquefasciatus was greater than that
shown by Olyset nets [12] or by nets treated with per-
methrin 500 mg/m2 [32] or carbosulfan 200 and 300 mg/
m2 [13,14,25]. The deterrency of chlorpyrifos-methyl was
still evidence presently after five washes. This contrasts
with another type of OP, pirimiphos -methyl which was
undetectable on nets after only 3 three washes [33]. The
difference partly lies with the formulations used. The
microencapsulated formulation was specially developed
to bind chlorpyrifos-methyl more strongly and to release
it more gradually compared to the emulsifiable concen-
trate used with pirimiphos -methyl. The manufacturer of
chlorpyrifos-methyl (Dow AgroSciences) has recently
improved the release characteristics and wash-fastness of
the microencapsulation so that insecticide persistence and
performance compares favourably with pyrethroids and
DDT (Rowland & Yates, unpublished). The microencap-
sulated formulation used for lambdacyhalothrin has been
shown earlier to withstand at least 5 washes [21,34] and
this was re-confirmed in the present trials.
Only a small proportion of mosquitoes in the hut with the
intact, untreated net had blood-fed. The protective effect
of untreated nets was lost when they were holed. This re-
confirms the results in experimental huts of Lines et al
[35] and Curtis et al [20] and data on malaria in children
sleeping under untreated nets which were either intact or
Table 2: Acetylcholinesterase genotypes as determined by PCR on Anopheles gambiae collected from the experimental huts.
Type of Treatment Live/dead at 
collection
Ace1R/Ace1R No. Ace1R/Ace1S Ace1S/Ace1S
No. % survival No. % survival
Untreated Control live 0 27 64%a 91 0 0 % b
dead 0 15 0
total 0 42 9
Chlorpyrifos- methyl live 1 23 26%c 11 46%c
dead 1 65 13
total 2 88 24
Lambda- cyhalothrin live 0 16 34%c 21 4 % c
dead 0 31 12
total 0 47 14
Mixture & two-in-one live 0 21 47%c 11 7 % c
dead 0 45 5
total 0 66 6
Note percentages accompanied by different letter superscripts differ significantly by χ 2 or Fisher's exact testMalaria Journal 2005, 4:25 http://www.malariajournal.com/content/4/1/25
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torn [36]. It emphasizes the point that ITN programmes
which fail to ensure that nets are and remain effectively
insecticidal cannot expect to achieve an impact on malaria
when the nets become torn, as they inevitably will.
Treatment with chlorpyrifos-methyl or lambdacyalothrin
restored the protectiveness of torn nets against Culex and
A. gambiae, as has been demonstrated with various pyre-
throid treatments [20,32,35,37].
Whether or not A. gambiae feeds through chlorpyrifos-
methyl treated nets seems to depend upon the concentra-
tion of insecticide used, the observed blood feeding rate
being zero for the net treated with 250 mg/m2 and 14.6%
with 100 mg/m2. Further tests with intermediate concen-
trations would be needed to confirm a dosage trend. Mor-
tality also appeared to be dosage-dependent, but the
difference between the doses was non-significant among
the small numbers collected.
Adverse effects involving headache and sneezing were
associated with exposure to nets recently treated with 250
mg/m2 chlorpyrifos-methyl. Such effects were not appar-
ent with nets treated with 100 mg/m2 chlorpyrifos-methyl
or with washed nets or with nets used two weeks after
treatment. Symptoms appeared to be dosage-dependent.
With lambdacyhalothrin treated nets, sneezing was
reported with a 30 mg/m2 dosage [38] and 20 mg/m2 [21]
but not at 10 mg/m2 [38] or with the dosage of lambdacy-
halothrin used in the present trial (18 mg/m2). While the
toxicological profile of chlorpyrifos-methyl is favourable,
a more comprehensive hazard assessment is warranted
before considering community trials [39,40]. To avoid the
side effects which were reported at 250 mg/m2, it is pro-
posed that a dose of 100 mg/m2 should not be exceeded.
Resistance due to insensitive acetylcholinesterase has
arisen independently through a point mutation to G119S
(glycine to serine substitution) of the Ace.1 gene on sev-
eral occasions in A. gambiae, Anopheles albimanus, C. quin-
quefaciatus and Culex pipiens [31]. This study confirms the
finding of Weill et al [31] on the same population of A.
gambiae  of there being far fewer homozygotes for the
Ace.1R than would be expected from the Hardy Weinberg
ratio, indicating extremely low viability of these homozy-
gotes. In the huts with untreated nets, the observed sur-
vival of heterozygotes for this gene was significantly less
than that of homozygotes for Ace.1S. With such strong
selection pressure against Ace.1R  at the adult stage in
homozygotes and heterozygotes, this gene could appar-
ently only persist in the population if there is very strong
selection against Ace.1S in the immature stages. A more
likely explanation is one of gene duplication having
occurred at the acetylcholinesterase locus. Such duplica-
tion of the Ace.1 locus is common in C. pipiens [31], and
the existence of such duplication in A. gambiae could
result in Ace.1S and Ace.1R being present at diffent loci on
the same chromosome. Insects with one locus for Ace.1S
and one for Ace.1R  could be included among those
labelled  Ace.1R/Ace.1S  in table 4. The rare individuals
labelled Ace.1R/Ace.1R in Table 2 would be those where
both Ace.1 loci and all alleles were of the R type.
The survival of all genotypes was significantly lower in
huts with treated nets than with untreated nets, and the
survival of mosquitoes with at least one Ace.1R allele and
those with only Ace.1S did not differ significantly on any
of the treatments. Thus under the realistic conditions of
the experimental huts the Ace.1R allele does not give effec-
tive resistance to chlorpyrifos-methyl.
The present study is the first experimental hut trial of chlo-
rpyrifos-methyl on nets. Other recent trials with non-pyre-
throids have focused on carbosulfan which, like
chlorpyrifos-methyl, is an acetylcholinesterase inhibitor
known to be effective against kdr resistant A. gambiae and
C. quinquefasciatus [13-15,25]. Quite apart from its poten-
tially toxic breakdown product, carbofuran [25], carbosul-
fan has the disadvantage of poorer wash fastness
compared to alphacyano-pyrethroids [14]. The rate of
conversion of carbosulfan to carbofuran and the hazard
this presents to net users has yet to be established, and the
inferior wash fastness might conceivably be improved
through formulation technology. But in view of these
uncertainties, chlorpyrifos-methyl seems the better pros-
pect at the present time. Chlorpyrifos-methyl should be
subjected to a full hazard assessment before being used on
a community scale [40].
There are several potential advantages to using combina-
tions of insecticide on nets: a) a reduced or delayed selec-
tion of resistance alleles, b) an improved control of
resistant populations, c) an improved efficacy if the two
components are synergistic, with possible cost savings and
improved safety if the dosage can be substantially reduced
as a result. To delay the selection of resistance with a mix-
ture would require no cross-resistance between the two
components and 100% mortality of insects carrying resist-
ance to one of the components on being exposed simulta-
neously to the other component [23,41]. The situation in
the Bouaké region of Côte d'Ivoire is not favourable to
classical resistance management of genes that have an
impact on chemical control, because kdr and Ace.1R are
already present at high frequency. Elsewhere in Africa,
where neither mechanism is present a strategy of using
mixtures of lambdacyhalothrin and chlorpyrifos-methyl
might have potential for resistance management. There is
some evidence in laboratory studies for synergy between
pyrethroids and OPs/carbamates against susceptible A.
gambiae adults [42] and resistant C. quinquefasciatus larvaeMalaria Journal 2005, 4:25 http://www.malariajournal.com/content/4/1/25
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bearing kdr and elevated oxidase mechanisms [43], but
not against adults with site-insensitivity resistance mecha-
nisms [44]. The encouragingly high efficacy of the low
dosage mixture could be due to synergism, but to test this
hypothesis a comparison should be made in experimental
huts with the low dosages applied individually to nets.
Both chlorpyrifos-methyl and lambdacyhalothrin treated
nets and combinations of these insecticides were shown
in the realistic conditions of experimental huts to be
equally effective in preventing blood feeding by, and kill-
ing of, A. gambiae and C. quinquefasciatus, which labora-
tory and molecular studies suggested would have shown
pyrethroid and organophosphate resistance. Thus, these
resistance genes may have little or no practical signifi-
cance. To demonstrate this unequivocally, it is desirable
to examine the impact of mixtures and single insecticide
treatments on both malaria transmission and the selec-
tion of resistance alleles in an area where resistance to OPs
and pyrethroids in A. gambiae and C. quinquefasciatus exist
at low-to-intermediate frequencies. Chlorpyrifos-methyl
should also be tested on nets and as an indoor residual
spray treatment against populations of pyrethroid resist-
ant C. quinquefasciatus (in Tanzania) and A. funestus (in
South Africa), respectively, that have demonstrated practi-
cal impact in the field [6,21]. Chlorpyrifos-methyl could
be useful for managing such problematic examples of
resistance if it could be shown that these pyrethroid resist-
ance mechanisms confer no cross- resistance to
organophosphates.
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